United States · FDA National Drug Code directory
Carbidopa and Levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-456_7a87848d-1fcb-4df6-ac7c-b506cc8dc95a
- Product NDC
- 59651-456
- Form
- TABLET
- Composition / generic term
- Carbidopa and Levodopa
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221128
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 10 mg/1
- LEVODOPA — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (59651-456-01) · 59651-456-01
- 500 TABLET in 1 BOTTLE (59651-456-05) · 59651-456-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →